Simple Summary In the last two decades, the use of small molecules as chemical inhibitors
of different targets in signaling pathways has been of great interest for therapeutic purposes …

Multiple myeloma (MM) is a common hematological malignancy. Although recent clinical
applications of immunomodulatory drugs, proteasome inhibitors and CD38-targeting …

Objective The mechanism of immunomodulatory drugs (IMiDs) resistance to multiple
myeloma (MM) cells has been gradually demonstrated by recently studies, and some …

Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of
ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a …

Objective Multiple myeloma is a haematological malignancy characterized by proliferation of
monoclonal plasma cells in the bone marrow. Development of resistance and minimal …

Resistance to therapy and disease progression are the main causes of mortality in most
cancers. In particular, the development of resistance is an important limitation affecting the …

In this paper we identify genes that could be principal in breast cancer primary tumor and its
firstmetastasis in lymph nodes, within biopsies in GEO and GDCDP database. By applying …